Evidence map›Paper›PMID 33174463›Full record

ArticleCurrent eye research2021

Association of Ocular Antihypertensive Medications and the Development and Progression of Age-related Macular Degeneration in a U.S. Insurance Claims Database.

Emily A Eton, Thomas J Wubben, Cagri G Besirli, Sophia Y Wang

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current eye research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 82% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Emily A EtonDepartment of Ophthalmology and Visual Sciences, University of Michigan, Kellogg Eye Center, Ann Arbor, Michigan, USA.ORCID 0000-0003-4212-7184
Thomas J WubbenDepartment of Ophthalmology and Visual Sciences, University of Michigan, Kellogg Eye Center, Ann Arbor, Michigan, USA.
Cagri G BesirliDepartment of Ophthalmology and Visual Sciences, University of Michigan, Kellogg Eye Center, Ann Arbor, Michigan, USA.
Sophia Y WangDepartment of Ophthalmology, Stanford University, Byers Eye Institute, Palo Alto, California, USA.
University of Michigan · USSmith-Kettlewell Eye Research Institute · US

Funding

VIVARIUM MODULEP30EY007003 · NEI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI David Antonetti · 1987 to 2026
$17.6M
Stanford Vision Research CoreP30EY026877 · NEI · STANFORD UNIVERSITY · PI Jeffrey L Goldberg · 2017 to 2026
$8.0M
Glutamine as an alternative fuel source for photoreceptorsK08EY031757 · NEI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WUBBEN, THOMAS JOSEPH · 2020 to 2024
$1.2M
NEI NIH HHS K08 EY031757NEI NIH HHS P30 EY007003NEI NIH HHS P30 EY026877
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AgedAged, 80 and overAntihypertensive AgentsDatabases, FactualDisease ProgressionFemaleGlaucoma, Open-AngleHumansInsurance Claim ReportingMacular DegenerationMaleManaged Care ProgramsMiddle AgedProportional Hazards ModelsRetrospective StudiesUnited StatesAntihypertensive AgentsAge-related macular degenerationocular antihypertensivesprimary open-angle glaucoma

Identifiers

PMID33174463
PMCPMC8187259
OpenAlexW3101123973

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.